The life sciences sector has been experiencing a boom in M&A activity, with deal volume in the first half of 2014 running at an unprecedented pace, both in terms of number of deals and aggregate deal volume. With more than $260 billion worth of deals announced in the first half of this year, the industry is up a staggering 220 percent over the same period in 2013, and is already ahead of the full-year deal volume for each of the pas...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In